Manon Fiorot has received a three-month suspension from the UFC after testing positive for trace amounts of Ostarine, a banned anabolic agent that violates the organization’s anti-doping policy. The French fighter accepted the sanction, which will remain in effect until 19 January 2027.
The suspension comes following Fiorot’s bout against fellow UFC flyweight Alexa Grasso on 12 September. The fight resulted in a loss for the French contender, adding to what has become a challenging period for the athlete.
Ostarine, a selective androgen receptor modulator (SARM), is prohibited under UFC regulations due to its performance-enhancing properties. The detection of even low levels of the substance triggered the anti-doping violation and subsequent disciplinary action against Fiorot.
Acceptance and Compliance
Fiorot’s acceptance of the ban marks a cooperative approach to the UFC’s anti-doping enforcement procedures. By acknowledging the violation and accepting the imposed suspension without contesting it, the fighter has expedited the resolution of the case rather than pursuing an extended appeal process.
The fighter’s compliance with the disciplinary decision demonstrates a willingness to adhere to the sport’s regulatory framework, though the suspension effectively sidelines her from competition during the specified period.